Report Detail
Global Dalteparin Sodium Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4695595 |
- 11 May, 2026 |
- Global |
- 103 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Dalteparin Sodium Injection market size was valued at US$ 1929 million in 2025 and is forecast to a readjusted size of US$ 2900 million by 2032 with a CAGR of 6.0% during review period.
Dalteparin Sodium Injection is a low molecular weight heparin (LMWH) anticoagulant used primarily for the prevention and treatment of thromboembolic disorders, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Its mechanism of action involves enhancing the activity of antithrombin III, thereby inhibiting coagulation factor Xa and reducing the risk of blood clot formation. This medication was developed to address the limitations of conventional heparin, such as unpredictable dosing, the need for frequent coagulation monitoring, and a higher risk of bleeding.
Dalteparin Sodium was first developed and clinically introduced in the 1990s. Its low molecular weight properties provide more predictable anticoagulant effects and lower adverse risks. The manufacturing process relies on upstream raw materials such as heparin and derivative chemical reagents, while essential components like injectable vials, rubber stoppers, and needles must meet pharmaceutical-grade standards. The supply chain is tightly controlled to ensure the safety and stability of the final product.In 2025, the global production capacity of dalteparin sodium injection was 150 million boxes, with sales volume reaching 118 million boxes, an average unit price of 15.8 USD per box, and corporate gross profit margins ranging between 25% and 35%.
Currently, the market for Dalteparin Sodium Injection is experiencing steady development both globally and within domestic healthcare systems. As a key low molecular weight heparin anticoagulant, it has earned broad clinical acceptance, particularly in perioperative anticoagulation, management of venous thromboembolic disorders, and prevention of cancer-associated thrombosis. The increasing prevalence of aging populations and cardiovascular-related diseases has led to sustained demand for anticoagulant therapies that are both safe and predictable, underpinning the clinical adoption and market penetration of dalteparin. Moreover, supportive drug reimbursement policies and the push for standardized anticoagulant use in medical institutions have helped normalize its role across multidisciplinary treatment contexts. Nonetheless, the competitive landscape is intensifying, especially with the rapid adoption of novel oral anticoagulants in certain indications, creating a degree of substitution pressure that challenges the dalteparin sodium injection market.
Looking ahead, evolving clinical treatment paradigms and the promotion of individualized anticoagulation strategies are expected to raise expectations for traditional anticoagulants, emphasizing not only efficacy and safety but also patient adherence and ease of use. This environment encourages ongoing innovation in product refinement, dosing regimens, and integrated patient management services for low molecular weight heparins including dalteparin. Advances in production technology and manufacturing processes are also likely to contribute to improved product consistency and cost optimization. Furthermore, deeper exploration in life sciences research may uncover new therapeutic indications and strengthen clinical evidence for combination therapies, offering fresh opportunities for market expansion. Enhanced anticoagulation safety monitoring and improved patient treatment experiences could become significant drivers of industry growth.
Despite a positive outlook, several inhibiting factors remain. Stricter regulatory environments demand higher standards for production quality control, leading to increased R&D, regulatory submission, and compliance costs and risks for manufacturers. At the same time, intense competition from generic products and price pressures compress profit margins, particularly for innovators. Clinical challenges remain in balancing bleeding risk assessments and accounting for patient heterogeneity, necessitating more comprehensive clinical pathways and evidence-based support. Additionally, variations in how healthcare systems select and utilize anticoagulants influence the depth and breadth of dalteparin sodium injection’s adoption across different regions.
This report is a detailed and comprehensive analysis for global Dalteparin Sodium Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Dalteparin Sodium Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dalteparin Sodium Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dalteparin Sodium Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dalteparin Sodium Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dalteparin Sodium Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dalteparin Sodium Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Hebei Changshan Biochemical Pharmaceutical Co.,Ltd., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Changzhou Qianhong Biopharma Co., Ltd., Qilu Pharmaceutical, Yantai Dongcheng Northern Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Dalteparin Sodium Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Dalteparin Sodium Injection 0.2ml:2500IU
Dalteparin Sodium Injection 0.2ml:5000IU
Dalteparin Sodium Injection 0.3ml:7500IU
Dalteparin Sodium Injection 0.5ml:12500IU
Dalteparin Sodium Injection 0.6ml:15000IU
Market segment by Packaging
Prefilled Syringe
Single-Dose Vial
Market segment by Manufacturing Process
Porcine Intestinal Mucosa Origin
Chemical Depolymerization
Nitrous Acid Depolymerization
Market segment by Application
Hospital
Nursing Institutions
Home Care
Others
Major players covered
Pfizer
Hebei Changshan Biochemical Pharmaceutical Co.,Ltd.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Changzhou Qianhong Biopharma Co., Ltd.
Qilu Pharmaceutical
Yantai Dongcheng Northern Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dalteparin Sodium Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dalteparin Sodium Injection, with price, sales quantity, revenue, and global market share of Dalteparin Sodium Injection from 2021 to 2026.
Chapter 3, the Dalteparin Sodium Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dalteparin Sodium Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Dalteparin Sodium Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dalteparin Sodium Injection.
Chapter 14 and 15, to describe Dalteparin Sodium Injection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Dalteparin Sodium Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Dalteparin Sodium Injection 0.2ml:2500IU
- 1.3.3 Dalteparin Sodium Injection 0.2ml:5000IU
- 1.3.4 Dalteparin Sodium Injection 0.3ml:7500IU
- 1.3.5 Dalteparin Sodium Injection 0.5ml:12500IU
- 1.3.6 Dalteparin Sodium Injection 0.6ml:15000IU
- 1.4 Market Analysis by Packaging
- 1.4.1 Overview: Global Dalteparin Sodium Injection Consumption Value by Packaging: 2021 Versus 2025 Versus 2032
- 1.4.2 Prefilled Syringe
- 1.4.3 Single-Dose Vial
- 1.5 Market Analysis by Manufacturing Process
- 1.5.1 Overview: Global Dalteparin Sodium Injection Consumption Value by Manufacturing Process: 2021 Versus 2025 Versus 2032
- 1.5.2 Porcine Intestinal Mucosa Origin
- 1.5.3 Chemical Depolymerization
- 1.5.4 Nitrous Acid Depolymerization
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Dalteparin Sodium Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospital
- 1.6.3 Nursing Institutions
- 1.6.4 Home Care
- 1.6.5 Others
- 1.7 Global Dalteparin Sodium Injection Market Size & Forecast
- 1.7.1 Global Dalteparin Sodium Injection Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Dalteparin Sodium Injection Sales Quantity (2021-2032)
- 1.7.3 Global Dalteparin Sodium Injection Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Pfizer
- 2.1.1 Pfizer Details
- 2.1.2 Pfizer Major Business
- 2.1.3 Pfizer Dalteparin Sodium Injection Product and Services
- 2.1.4 Pfizer Dalteparin Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Pfizer Recent Developments/Updates
- 2.2 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd.
- 2.2.1 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Details
- 2.2.2 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Major Business
- 2.2.3 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Product and Services
- 2.2.4 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Recent Developments/Updates
- 2.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
- 2.3.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Details
- 2.3.2 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Major Business
- 2.3.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Product and Services
- 2.3.4 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
- 2.4 Changzhou Qianhong Biopharma Co., Ltd.
- 2.4.1 Changzhou Qianhong Biopharma Co., Ltd. Details
- 2.4.2 Changzhou Qianhong Biopharma Co., Ltd. Major Business
- 2.4.3 Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Product and Services
- 2.4.4 Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Changzhou Qianhong Biopharma Co., Ltd. Recent Developments/Updates
- 2.5 Qilu Pharmaceutical
- 2.5.1 Qilu Pharmaceutical Details
- 2.5.2 Qilu Pharmaceutical Major Business
- 2.5.3 Qilu Pharmaceutical Dalteparin Sodium Injection Product and Services
- 2.5.4 Qilu Pharmaceutical Dalteparin Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Qilu Pharmaceutical Recent Developments/Updates
- 2.6 Yantai Dongcheng Northern Pharmaceutical
- 2.6.1 Yantai Dongcheng Northern Pharmaceutical Details
- 2.6.2 Yantai Dongcheng Northern Pharmaceutical Major Business
- 2.6.3 Yantai Dongcheng Northern Pharmaceutical Dalteparin Sodium Injection Product and Services
- 2.6.4 Yantai Dongcheng Northern Pharmaceutical Dalteparin Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Yantai Dongcheng Northern Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Dalteparin Sodium Injection by Manufacturer
- 3.1 Global Dalteparin Sodium Injection Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Dalteparin Sodium Injection Revenue by Manufacturer (2021-2026)
- 3.3 Global Dalteparin Sodium Injection Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Dalteparin Sodium Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Dalteparin Sodium Injection Manufacturer Market Share in 2025
- 3.4.3 Top 6 Dalteparin Sodium Injection Manufacturer Market Share in 2025
- 3.5 Dalteparin Sodium Injection Market: Overall Company Footprint Analysis
- 3.5.1 Dalteparin Sodium Injection Market: Region Footprint
- 3.5.2 Dalteparin Sodium Injection Market: Company Product Type Footprint
- 3.5.3 Dalteparin Sodium Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Dalteparin Sodium Injection Market Size by Region
- 4.1.1 Global Dalteparin Sodium Injection Sales Quantity by Region (2021-2032)
- 4.1.2 Global Dalteparin Sodium Injection Consumption Value by Region (2021-2032)
- 4.1.3 Global Dalteparin Sodium Injection Average Price by Region (2021-2032)
- 4.2 North America Dalteparin Sodium Injection Consumption Value (2021-2032)
- 4.3 Europe Dalteparin Sodium Injection Consumption Value (2021-2032)
- 4.4 Asia-Pacific Dalteparin Sodium Injection Consumption Value (2021-2032)
- 4.5 South America Dalteparin Sodium Injection Consumption Value (2021-2032)
- 4.6 Middle East & Africa Dalteparin Sodium Injection Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Dalteparin Sodium Injection Sales Quantity by Type (2021-2032)
- 5.2 Global Dalteparin Sodium Injection Consumption Value by Type (2021-2032)
- 5.3 Global Dalteparin Sodium Injection Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Dalteparin Sodium Injection Sales Quantity by Application (2021-2032)
- 6.2 Global Dalteparin Sodium Injection Consumption Value by Application (2021-2032)
- 6.3 Global Dalteparin Sodium Injection Average Price by Application (2021-2032)
7 North America
- 7.1 North America Dalteparin Sodium Injection Sales Quantity by Type (2021-2032)
- 7.2 North America Dalteparin Sodium Injection Sales Quantity by Application (2021-2032)
- 7.3 North America Dalteparin Sodium Injection Market Size by Country
- 7.3.1 North America Dalteparin Sodium Injection Sales Quantity by Country (2021-2032)
- 7.3.2 North America Dalteparin Sodium Injection Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Dalteparin Sodium Injection Sales Quantity by Type (2021-2032)
- 8.2 Europe Dalteparin Sodium Injection Sales Quantity by Application (2021-2032)
- 8.3 Europe Dalteparin Sodium Injection Market Size by Country
- 8.3.1 Europe Dalteparin Sodium Injection Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Dalteparin Sodium Injection Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Dalteparin Sodium Injection Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Dalteparin Sodium Injection Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Dalteparin Sodium Injection Market Size by Region
- 9.3.1 Asia-Pacific Dalteparin Sodium Injection Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Dalteparin Sodium Injection Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Dalteparin Sodium Injection Sales Quantity by Type (2021-2032)
- 10.2 South America Dalteparin Sodium Injection Sales Quantity by Application (2021-2032)
- 10.3 South America Dalteparin Sodium Injection Market Size by Country
- 10.3.1 South America Dalteparin Sodium Injection Sales Quantity by Country (2021-2032)
- 10.3.2 South America Dalteparin Sodium Injection Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Dalteparin Sodium Injection Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Dalteparin Sodium Injection Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Dalteparin Sodium Injection Market Size by Country
- 11.3.1 Middle East & Africa Dalteparin Sodium Injection Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Dalteparin Sodium Injection Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Dalteparin Sodium Injection Market Drivers
- 12.2 Dalteparin Sodium Injection Market Restraints
- 12.3 Dalteparin Sodium Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Dalteparin Sodium Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Dalteparin Sodium Injection
- 13.3 Dalteparin Sodium Injection Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Dalteparin Sodium Injection Typical Distributors
- 14.3 Dalteparin Sodium Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Dalteparin Sodium Injection. Industry analysis & Market Report on Dalteparin Sodium Injection is a syndicated market report, published as Global Dalteparin Sodium Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Dalteparin Sodium Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
